Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026)

Mirum Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $569.4 million for Q1 2026.

• In Q1 2026, Current Assets rose 38.61% year-over-year to $569.4 million; the TTM figure through Mar 2026 stood at $569.4 million (up 38.61% YoY), while the FY2025 annual figure was $549.7 million, up 39.94% from the prior year.
• Current Assets was $569.4 million for Q1 2026 at Mirum Pharmaceuticals, up from $549.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $569.4 million in Q1 2026 to a low of $147.2 million in Q2 2022.
• Historically, Current Assets has averaged $358.3 million across 5 years, with a median of $387.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Current Assets plunged 35.52% in 2022, then soared 160.46% in 2023.
• A 5-year view of Current Assets shows it stood at $190.2 million in 2022, then surged by 103.73% to $387.5 million in 2023, then rose by 1.35% to $392.8 million in 2024, then jumped by 39.94% to $549.7 million in 2025, then rose by 3.59% to $569.4 million in 2026.
• The last three Current Assets figures came in at $569.4 million (Q1 2026), $549.7 million (Q4 2025), and $530.6 million (Q3 2025), per Business Quant data.